831. Deputy Conor Sheehan asked the Minister for Health the number of WTE public health nurse posts filled within CHO3 in each of the years of 2023, 2024 and to-date in 2025, in tabular form; and if she will make a statement on the matter. [69018/25]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
1,111 questions match, newest first.
832. Deputy Conor Sheehan asked the Minister for Health the number of WTE consultant cardiologists based at University Hospital Limerick in each of the years of 2023, 2024 and to-date in 2025, in tabular form; and if she will make a statement on the matter. [69019/25]
833. Deputy Marie Sherlock asked the Minister for Health the average cost per unit of a holter monitor device; and if she will make a statement on the matter. [69025/25]
834. Deputy Conor D. McGuinness asked the Minister for Health the action she will take in an urgent neurosurgical case for a person (details supplied) where the patient has been placed on a lengthy waiting list despite clinical advice that surgery is required promptly; and if she will ensure the HSE provides an expedited review and treatment date. [69028/25]
835. Deputy Conor D. McGuinness asked the Minister for Health if shunt replacement or similar neurosurgical procedures are eligible for support through the cross-border healthcare scheme, the treatment abroad scheme, or the national treatment purchase fund, particularly in cases where significant delays exist in accessing such treatment in the State; and the criteria governing access to each scheme. [69029/25]
836. Deputy Sorca Clarke asked the Minister for Health the waiting list figures for CAMHS services at the end of November 2025, by county; and if she will make a statement on the matter. [69030/25]
837. Deputy Catherine Callaghan asked the Minister for Health the total amount of HSE funding that has been provided to a service (details supplied) since the WRC agreement in 2023; the dates these payments were made; and if she will make a statement on the matter. [69038/25]
838. Deputy Catherine Callaghan asked the Minister for Health the engagement which the HSE has had with a service (details supplied) in 2025 regarding the implementation of the agreed 8% uplift which is due to staff; and if she will make a statement on the matter. [69039/25]
839. Deputy Catherine Callaghan asked the Minister for Health the operational impact on Accident and Emergency Departments she is preparing for, in advance of the proposed strike action by a service (details supplied) on 18 December 2025 and the subsequent dates that are planned for week commencing 22 December 2025, as members of the public will not have access to out of hours services; and if she will make a stateme…
840. Deputy Robert O'Donoghue asked the Minister for Health her views on the fact that approximately 9,000 women are currently waiting up to 10 weeks or longer for a follow-up appointment after being referred by their GP for suspected breast cancer; the reason such delays are occurring; the clinical risk posed by these waiting times; the actions she is taking to ensure that urgent breast care referrals are assessed w…
841. Deputy Robert O'Donoghue asked the Minister for Health the clinical consequences identified by her Department and the HSE regarding prolonged delays in breast cancer follow-up appointments; the number of cases that have breached the recommended urgent referral timeframe; the measures which are being implemented to safeguard early detection and timely diagnosis; and if she will make a statement on the matter. [69…
842. Deputy Robert O'Donoghue asked the Minister for Health the status of out-of-date, old or non-compliant diagnostic equipment in breast cancer assessment units; the number of machines requiring replacement or upgrade; the timeline for bringing all breast units in line with modern clinical standards; and if she will make a statement on the matter. [69043/25]
843. Deputy Robert O'Donoghue asked the Minister for Health when funding will be formally allocated to replace outdated breast diagnostic equipment; the reason for the delay in confirming this funding; and whether the 2026 capital plan includes specific ring-fenced investment for breast cancer services; and if she will make a statement on the matter. [69044/25]
844. Deputy Robert O'Donoghue asked the Minister for Health the recruitment, staffing, and capacity challenges contributing to delays in breast cancer follow-up appointments; the number of vacant consultant, radiographer, and breast care nurse posts nationally; the plan to address these gaps; and if she will make a statement on the matter. [69045/25]
845. Deputy Robert O'Donoghue asked the Minister for Health the way in which current waiting times for breast cancer follow-up appointments align with the targets set out in the National Cancer Strategy; the accountability measures which exist for persistent breaches of these targets; and if she will make a statement on the matter. [69046/25]
846. Deputy Robert O'Donoghue asked the Minister for Health the immediate actions, such as extended clinic hours, outsourcing of scans, or temporary capacity expansion, which are being considered to reduce the backlog of 9,000 women awaiting follow-up appointments; the projected timeline for clearing this backlog; and if she will make a statement on the matter. [69047/25]
847. Deputy Mairéad Farrell asked the Minister for Health the work her Department is doing to progress the approval from HSE Medicines Management Programme for dupilumab for the treatment of paediatric eosinophilic oesophagitis; and if she will make a statement on the matter. [69050/25]
848. Deputy Pat Buckley asked the Minister for Health if the case of a person (details supplied) will be reviewed; and if she will make a statement on the matter. [69051/25]
849. Deputy Ken O'Flynn asked the Minister for Health the governance framework applied by her Department to non-statutory bodies that receive direct funding, including the internal controls, verification steps, and oversight mechanisms used prior to releasing public funds. [69066/25]
850. Deputy Ken O'Flynn asked the Minister for Health the due diligence process carried out before funding is approved for non-statutory bodies; the risk assessments completed; and the measures taken to ensure appropriate stewardship of Exchequer funds. [69067/25]
851. Deputy Ken O'Flynn asked the Minister for Health if she intends to introduce standardised reporting requirements, annual financial statements, audit obligations or sanctions for non-statutory bodies receiving direct funding from her Department; and any reforms now under consideration. [69068/25]
852. Deputy Ken O'Flynn asked the Minister for Health the number of applications approved under the treatment abroad scheme for gender-affirming surgery; the number of applications refused; and the total cost to the State in each year, including associated clinical and administrative costs, from 2018 to 2025, by year. [69088/25]
853. Deputy Ken O'Flynn asked the Minister for Health if she is satisfied that the current approval process for gender-affirming surgery under the treatment abroad scheme operates without any standardised national clinical review panel or centralised governance structure; the steps she intends to take to introduce national oversight; and when such measures will be operational. [69089/25]
854. Deputy Ken O'Flynn asked the Minister for Health the number of referring consultants in Ireland who have issued the clinical recommendation and multidisciplinary-team letters relied upon for treatment abroad scheme approvals for gender-affirming surgery; the clinical specialties of these consultants; and the number of such recommendations issued in each of the years 2018 to 2025. [69090/25]
855. Deputy Ken O'Flynn asked the Minister for Health the criteria used by her Department to determine which gender-affirming procedures are eligible for approval under the treatment abroad scheme; the clinical basis for excluding procedures such as facial feminisation surgery; and whether a review of these criteria is underway or planned. [69091/25]